Study of the Safety and Pharmacokinetics of BGB-3111 in Subjects With B-Cell Lymphoid Malignancies

Clinical trial NCT02343120 · COMPLETED

Trial details

NCT number: NCT02343120
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Malignancies

Start date: 2014-09-04
Primary completion: 2021-03-31
Enrollment: 385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.